A Nasal Anti-depressant Spray that Reduces the Risk of Suicide
Johnson & Johnson’s Spravato is approved as the first-ever nasal anti-depressant to reduce the risk of suicide in people. This approval has been granted considering the high impact of the on-going pandemic on the mental health of the common public. The U.S Food and Drug Administration (FDA) has granted this fast track approval to this…